Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Merck KGaA presents phase I data for the novel antimalarial candidate M-5717

Nov. 28, 2019

Patient recruitment ongoing in phase I/II study of BTZ-043 in pulmonary tuberculosis

Nov. 28, 2019

A whole parasite vaccination approach against malaria presented

Nov. 28, 2019

Bayer identifies new quinoline derivatives

Nov. 27, 2019

DNDi receives financial support development of drugs for sleeping sickness and river blindness

Nov. 27, 2019

There's an app for that?!: web-based tool facilitates new antibiotic development

Nov. 27, 2019

Takeda Vaccines presents data on TAK-426 for Zika virus

Nov. 26, 2019

TFF Pharmaceuticals initiates phase I study of voriconazole inhalation powder

Nov. 26, 2019

Antifilarial therapy against onchocerciasis presented

Nov. 26, 2019

Johnson & Johnson identifies new anti-HBV compounds

Nov. 25, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...